If your work requires sharp cognitive function, GLP-1 medications do not carry this risk
At True Jewel Cosmetic Center in Santa Monica, we pride ourselves on our personalized and sympathetic approach to Semaglutide weight loss treatments
Image Credit: AtlasStudio / Shutterstock A recent editorial published in the journal Expert Opinion on Pharmacotherapy discussed that glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) may potentially transform health outcomes for individuals with serious mental illnesses (SMIs)
Please like, comment, and follow
Published: July 26, 2023 *Corresponding author: Nasser Mikhail, Department of Medicine, Olive View-UCLA Medical Center, David-Geffen UCLA Medical School, USA, Email: [email protected] How to cite this article: Nasser M, Soma W